Literature DB >> 6237015

Effect of insulin and transferrin in the maintenance of the activated state of the T-lymphocyte induced by allo-antigen.

J H Helderman, R Gruchalla, L E Edwards.   

Abstract

Insulin is an immuno-modulating molecule enhancing cytotoxic T-cell function and supporting intermediary metabolism in activated lymphocytes. Insulin also maintains the activated state of mitogen-stimulated lymphocytes. Because of the importance of allo-antigen response of diabetic patients for infections and transplant immunity, we explored the role of insulin in the allo-activated state of lymphocytes. Allo-stimulation was provided in one-way mixed lymphocyte reactions, with Balb/C mouse lymph node cells responding to irradiated spleen cells of C57BL/6 mice, in culture under conditions which permitted evaluation of hormonal modulation. Mixed lymphocyte reactions established in fetal calf serum, insulin-depleted by passage over antibody affinity columns, were of equal magnitude to those in insulin-replete serum. A weak but positive mixed lymphocyte reaction can be effected with an artificial serum substitute containing no additional hormone. Provision of insulin (10 nmol/l) restored a full mixed lymphocyte reaction response which was mimicked by addition of transferrin. The insulin-transferrin combination was not additive. In conclusion, insulin and transferrin maintain the allo-activated state of the mouse lymphocyte, transferrin alone being sufficient when full antigenic stimulation is provided. If the same applies to human lymphocytes, insulin-deficient diabetic patients will respond to full allo-antigen challenge, and so should be fully capable of mounting a transplant immune response.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6237015     DOI: 10.1007/bf00275659

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  9 in total

1.  Immunoassay of endogenous plasma insulin in man.

Authors:  R S YALOW; S A BERSON
Journal:  J Clin Invest       Date:  1960-07       Impact factor: 14.808

2.  THE NATURE OF THE LOWERED RESISTANCE TO INFECTION IN DIABETES MELLITUS.

Authors:  A Marble; H J White; A T Fernald
Journal:  J Clin Invest       Date:  1938-07       Impact factor: 14.808

3.  Cell-mediated immunity in diabetes mellitus.

Authors:  G Delespesse; J Duchateau; P A Bastenie; J P Lauvaux; H Collet; A Govaerts
Journal:  Clin Exp Immunol       Date:  1974-12       Impact factor: 4.330

4.  Coated charcoal immunoassay of insulin.

Authors:  V Herbert; K S Lau; C W Gottlieb; S J Bleicher
Journal:  J Clin Endocrinol Metab       Date:  1965-10       Impact factor: 5.958

5.  Cell-mediated immunity in diabetes mellitus.

Authors:  J F Plouffe; J Silva; R Fekety; J L Allen
Journal:  Infect Immun       Date:  1978-08       Impact factor: 3.441

6.  The role of insulin in the response of murine T lymphocytes to mitogenic stimulation in vitro.

Authors:  E C Snow; T L Feldbush; J A Oaks
Journal:  J Immunol       Date:  1980-02       Impact factor: 5.422

7.  Role of insulin in the intermediary metabolism of the activated thymic-derived lymphocyte.

Authors:  J H Helderman
Journal:  J Clin Invest       Date:  1981-06       Impact factor: 14.808

8.  Emergence of insulin receptors upon alloimmune T cells in the rat.

Authors:  J H Helderman; T B Strom
Journal:  J Clin Invest       Date:  1977-02       Impact factor: 14.808

9.  In vitro regeneration of resting lymphocytes from stimulated lymphocytes and its inhibition by insulin.

Authors:  J Kumagai; H Akiyama; S Iwashita; H Iida; I Yahara
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

  9 in total
  1 in total

1.  Monocyte-T lymphocyte interaction for regulation of insulin receptors of the activated T lymphocyte.

Authors:  J H Helderman; R Ayuso; J Rosenstock; P Raskin
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.